Pfizer
Debjit Biswas has extensive work experience in the pharmaceutical and biotechnology industry. Debjit has held various leadership positions in well-known companies such as Pfizer, Ablynx, Piramal Enterprises Limited, and Bristol-Myers Squibb. Debjit'sroles have included overseeing clinical development activities, managing biometrics resources and deliverables, and providing strategic input for development strategies and project plans. Additionally, Debjit has served as the President of the Indian Association for Statistics in Clinical Trials. Debjit has a strong background in biostatistics and has contributed to the filing and approval of medications for the treatment of various conditions. Prior to their industry experience, Debjit worked as a Research Scientist at GE Global Research and held academic positions at the University of Michigan and Wayne State University School of Medicine.
Debjit Biswas completed their education in a chronological manner. Debjit first attended South Point High School in Kolkata from 1977 to 1989, where they completed their Higher Secondary education in the field of Science. Following this, they enrolled at the Indian Statistical Institute in Kolkata from 1989 to 1994, obtaining both a B.Stat. and M.Stat. degree in Statistics. Lastly, they pursued a Ph.D. in Statistics from the University of Michigan, where they attended from 1994 to 1999.
This person is not in any teams
This person is not in any offices
Pfizer
614 followers
Pfizer Inc. is a research-based, global biopharmaceutical company. They apply science and their global resources to bring therapies to people that extend and significantly improve their lives through the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. They work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Pfizer collaborates with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world. Pfizer was founded in 1942. Most of Pfizer’s revenues come from the manufacture and sale of biopharmaceutical products. They believe that their medicines and vaccines provide significant value for healthcare providers and patients, through improved treatment of diseases, improvements in health, wellness and productivity as well as by reducing other healthcare costs, such as emergency room or hospitalization. Pfizer is committed to fulfilling their purpose: Breakthroughs that change patients’ lives. Their purpose fuels everything they do and reflects both their passion for science and commitment to patients. Pfizer’s growth strategy is driven by five “Bold Moves” that help them deliver breakthroughs for patients and create value for shareholders and other stakeholders: 1. Unleash the power of our people; 2. Deliver first-in-class science; 3. Transform our go-to-market model; 4. Win the digital race in pharma; and 5. Lead the conversation.